Bayer

Bayer’s Vitravki Faces Pricing Hurdles

Thiacloprid now Effectively Banned in the EU

Bayer to Appeal Hardeman Roundup Verdict

Lanxess Managing Board Gets Female Member

FTC Move Delays Bayer-Elanco Deal

Innovative Chemistry Between Mountains and Lakes

Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan, as well as EU facilities in the United Kingdom and Germany. But do not underestimate the role of the domestic regional clusters and industrial sites.

The Chemical and Pharmaceutical Industry in Eastern Germany

Bayer Agrees to Delay two more Roundup trials

Made in Switzerland – Exported Worldwide

Bayer Animal Health Links With Pharmaron

Bayer Completes Sale of Currenta Stake

Bayer/Monsanto Win Brazilian Seed Patent Challenge

Bayer’s Roundup Lawsuits Doubled Since July

Bayer Animal Health and VLPbio to Collaborate

EU Adds Thiacloprid to Neonic Restrictions

Third Roundup Trial Postponed to early 2020

Bayer Cuts Two Management Board Members

Bayer Says Monsanto Stakeholder Lists Lawful

Continuous Processing

Sustainable Chemical Supply Chains

Germany Moves Toward Glyphosate Phase-out

Bayer to Sell Animal Health to Elanco

Syngenta-funded paper Says Glyphosate Best at Dawn

Bayer Ready to Wind up Glyphosate Suits?

Bayer Buys Cell Therapy Specialist BlueRock

Bayer and Lanxess Divest Currenta Stakes

Bayer Faces 5,000 new Roundup Lawsuits

Damages Reduced in Third Roundup Verdict

Yellow Wood to Buy Dr. Scholl’s from Bayer

Bayer and Elanco Animal Health Link-up?

Judge Cuts Roundup Award by $55 Million

Bayer may Settle Roundup Cases out of Court

Analysts Tell Bayer to Shape up, or Split

Bayer Files Appeal of $2 Billion Roundup Award

Monsanto List Targeted 600 in Germany and France